Microfluidic Alginate Microparticles for Size and Shape Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
It is challenging to produce hydrogel microparticles with defined shapes and sizes less than 50 μm and to control the distribution of crosslinking agents for structural homogeneity and reproducibility.
Innovation Solution
The development of microparticles using microfluidic techniques to form crosslinked gel microparticles with controlled size, shape, and morphology, including core-shell and Janus-type structures, using alginate and Ca2+-EDTA, with a coefficient of variation in size distribution from 0.03 to 0.05, allowing for encapsulation of cells and active agents.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional gelation methods are used to form microparticles, then the process is simple, but the microparticles cannot achieve defined shapes and sizes less than 50 μm with high monodispersity
Solution Approach 1:
The invention segments the gelation process into distinct microfluidic stages: droplet formation with controlled size, crosslinking agent introduction, and gelation. This segmentation enables precise control over microparticle dimensions (achieving <50 μm with CV<0.05) and shape while using standardized microfluidic components
Solution Approach 2:
The invention transitions from conventional bulk gelation to microfluidic droplet-based gelation, adding the dimension of precise flow control and interfacial reaction. This dimensional shift enables defined shapes (spheres, rods, crescents) and sizes <50 μm that are inaccessible through traditional methods
2Stability of the object's composition
If crosslinking agents are added to form gel microparticles, then gelation occurs, but the distribution of crosslinking agent cannot be controlled for structural homogeneity
Solution Approach 1:
The crosslinking agent is pre-introduced into the droplet along with the polymer solution before gelation begins. This preliminary action ensures uniform distribution of the crosslinking agent throughout the droplet volume, leading to homogeneous gel structure and consistent mechanical properties
Solution Approach 2:
The microfluidic system maintains homogeneous mixing of polymer and crosslinking agent within each droplet through controlled flow rates and rapid mixing at the junction. This homogeneity principle ensures uniform crosslinking density throughout the microparticle structure
3Manufacturing precision
If microparticle size is reduced to less than 50 μm, then higher monodispersity is achieved, but production difficulty increases significantly
Solution Approach 1:
The invention replaces mechanical size control methods (screening, filtration, centrifugation) with flow-based microfluidic control. The droplet size is determined by flow rates and channel geometry rather than mechanical separation, enabling <50 μm particles with CV<0.05 to be produced directly in a single step
4Manufacturing precision
If defined shapes and sizes are achieved through microfluidic techniques, then manufacturing precision improves, but device complexity increases
Solution Approach 1:
The microfluidic device uses universal T-junction or flow-focusing geometries that can produce multiple shapes (spheres, rods, crescents) by simply adjusting flow rates and channel dimensions. This multi-functionality reduces the need for complex dedicated fixtures for each particle geometry
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the creation of monodisperse, structurally homogeneous microparticles suitable for various applications, including pharmaceuticals, cosmetics, and tissue engineering, with improved drug delivery and regenerative medicine capabilities, and enhanced biological accuracy in cell-based tests.
Implementation Method 1
Microfluidic techniques can be used to prepare rods, crescents, hooks, as well as core-shell microparticles
Implementation Method 2
using alginate and Ca2+-EDTA, with a coefficient of variation in size distribution from 0.03 to 0.05
Implementation Method 3
encapsulation of cells and active agents
Data Source
AI summary
The invention relates to microparticles comprising a crosslinked gel and methods for making and using same.


